S
Stuart Johnson
Researcher at Loyola University Medical Center
Publications - 170
Citations - 19584
Stuart Johnson is an academic researcher from Loyola University Medical Center. The author has contributed to research in topics: Clostridium difficile & Vancomycin. The author has an hindex of 56, co-authored 148 publications receiving 18018 citations. Previous affiliations of Stuart Johnson include United States Department of Veterans Affairs & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen,Dale N. Gerding,Stuart Johnson,Ciaran P. Kelly,Vivian G. Loo,L. Clifford McDonald,Jacques Pépin,Mark H. Wilcox +7 more
TL;DR: This guideline updates recommendations regarding epidemiology, diagnosis, treatment, and infection control and environmental management of Clostridium difficile.
Journal ArticleDOI
An epidemic, toxin gene-variant strain of Clostridium difficile.
L. Clifford McDonald,George Killgore,Angela Thompson,Robert C. Owens,Sophia Kazakova,Susan P. Sambol,Stuart Johnson,Dale N. Gerding +7 more
TL;DR: A previously uncommon strain of C. difficile with variations in toxin genes has become more resistant to fluoroquinolones and has emerged as a cause of geographically dispersed outbreaks of C.'s Difficile-associated disease.
Journal ArticleDOI
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald,Dale N. Gerding,Stuart Johnson,Stuart Johnson,Johan S. Bakken,Karen C. Carroll,Susan E. Coffin,Erik R. Dubberke,Kevin W. Garey,Carolyn V. Gould,Ciaran P. Kelly,Vivian G. Loo,Julia S. Sammons,Thomas J. Sandora,Mark H. Wilcox +14 more
TL;DR: This guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management on Clostridium difficile infection in adults and includes recommendations for children.
Journal ArticleDOI
Toxin B is essential for virulence of Clostridium difficile
Dena Lyras,Jennifer R. O'Connor,Pauline Howarth,Susan P. Sambol,Glen P. Carter,Tongted Phumoonna,Rachael Poon,Victoria Michelle Adams,Gayatri Vedantam,Stuart Johnson,Dale N. Gerding,Julian I. Rood +11 more
TL;DR: The construction of isogenic tcdA and tcdB mutants of a virulent C. difficile strain are described and their use in the hamster disease model is used to show that toxin B is a key virulence determinant.
Journal ArticleDOI
Clostridium difficile-associated diarrhea and colitis
TL;DR: The status of diagnosis, epidemiology, infection control, and treatment of Clostridium difficile -associated disease is reviewed and a case definition of CDAD is defined.